Publication | Open Access

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

EsophagusEsophageal CancerGastrointestinal OncologyMedicineGastroenterologyPathologyPhase Ii StudyUntreated Advanced GastricOncologyRadiation OncologyCancer ResearchFolcetux Study